Immediate Impact
2 from Science/Nature 164 standout
Citing Papers
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
Works of Gabriel Kim being referenced
Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus
2015
Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Gabriel Kim | 1269 | 647 | 677 | 16 | 1.4k | |
| Albert Fung | 1167 | 580 | 528 | 16 | 1.3k | |
| Arnaud Bastien | 990 | 501 | 559 | 15 | 1.1k | |
| Eleni Athanasiadou | 1250 | 602 | 455 | 20 | 1.5k | |
| Sabine Pinnetti | 1429 | 848 | 776 | 21 | 1.5k | |
| Katja Rohwedder | 1207 | 567 | 686 | 33 | 1.3k | |
| Ludwig Merker | 1286 | 704 | 521 | 29 | 1.4k | |
| Elke Seewaldt-Becker | 945 | 581 | 503 | 7 | 1.0k | |
| Elise Hardy | 1242 | 510 | 628 | 37 | 1.3k | |
| Thomas Hach | 816 | 434 | 500 | 37 | 1.1k | |
| Sue Sha | 1228 | 724 | 423 | 18 | 1.5k |
All Works
Loading papers...